Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18077ExperimentalSmall molecule
CPZEN-45: Overview.
- Formula / weight
- C32H44N6O11 · 688.735 g/mol (avg)
- Also known as
- 5-{[(5-amino-3,3-dihydroxyoxolan-2-yl)oxy][5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl}-N-(4-butylphenyl)-4,7-dimethyl-6-oxocyclohept-1-ene-1-carboxamide · Uridine, 5'-o-(5-amino-5-deoxy-.beta.-d-ribofuranosyl)-5'-c-((2s)-5-(((4-butylphenyl)amino)carbonyl)-2,3,4,7-tetrahydro-1,4-dimethyl-3-oxo-1h-1,4-diazepin-2-yl)-, (5's)-
- Code names
- CPZEN-45
Resolves to
Structure
InChIKey
RQVDLVWYEOCAJE-KDHSHZOVSA-NSMILES[H][C@@]1(O[C@H]([C@@]2([H])O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@]2([H])N(C)CC=C(N(C)C2=O)C(=O)NC2=CC=C(CCCC)C=C2)O[C@H](CN)[C@@H](O)[C@H]1OWhich companies are running trials of CPZEN-45, in which indications and phases, and which of those programs are still active?